Pixium Vision - End of ESGO arrangement comes as no surprise
Pixium has terminated its convertible note financing arrangement with the European Select Growth Opportunities Fund (ESGO) without any penalties....
196 Views
Pixium Vision - Next-generation implant chip highlighted
Pixium has announced the publication of data in three peer reviewed journals highlighting that its second-generation (2G) Prima sub-retinal implant...
114 Views
Pixium Vision - PRIMAvera implantations now completed
Meeting its prior guidance, Pixium Vision has now completed all of the implantations required as part of the PRIMAvera pivotal trial assessing the...
677 Views
Pixium Vision - PRIMAvera reaches full enrolment
Meeting its prior guidance, Pixium Vision announced that it has now reached its enrolment target of 38 patients for the PRIMAvera pivotal trial...
678 Views
Pixium Vision - First Prima implantation in Italy
Pixium Vision announced the successful first implantation of a patient in Italy as part of the PRIMAvera pivotal trial assessing the wireless Prima...
667 Views